Stock Price Quote

MERCURY LABORATORIES LTD.

NSE : NABSE : 538964ISIN CODE : INE947G01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE849.0030.9 (+3.78 %)
PREV CLOSE ( ) 818.10
OPEN PRICE ( ) 834.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 47
TODAY'S LOW / HIGH ( )785.00 869.00
52 WK LOW / HIGH ( ) 7601190
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-02 1982
Management Info
Bharat Mehta - Chairman Rajendra R Shah - Managing Director
Registered Office

Address 18, Shreeji Bhuvan,51, Mangaldas Road,Princess Street,
Mumbai,
Maharashtra-400002

Phone 022 66372841

Email mllbom@mtnl.net.in / mllbrd@mercurylabs.com / secretarial@mercurylabs.com

Website www.mercurylabs.com

Registrars Details
MUFG Intime India Pvt Ltd.
Geetakunu, 1, Bhakti Nagar Society,Behind ABS Tower,Old Padra Road,Vadodara
Listing : BSE, OTCEI

NEWS

14Feb Mercury Laboratories informs about new
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Re..
16Nov Mercury Laboratories informs about new
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Re..
07Oct Mercury Laboratories informs about com
Mercury Laboratories has enclosed a certificate under regulation 74(5) o..
13Sep Mercury Laboratories informs about los
In compliance with Regulation 39(3) of the Securities and Exchange Board..
03Sep Mercury Laboratories informs about new
Mercury Laboratories has enclosed newspaper cuttings for publication of..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit11.9256.5499999999999
Gross Profit 16.42 69.2099999999999
Operating Profit 25.04101.2
Net Sales 195.72755.59

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Ajanta Pharma (BSE)
peergroup  2558.40 (2.61%)
M.Cap ( in Cr)31957.51
Coral Laboratories (BSE)
peergroup  807.60 (8.54%)
M.Cap ( in Cr)288.52
Vimta Labs (BSE)
peergroup  1119.70 (3.91%)
M.Cap ( in Cr)2488.29
Aarti Drugs (BSE)
peergroup  410.85 (7.20%)
M.Cap ( in Cr)3749.83
Glaxosmithkline Phar (BSE)
peergroup  2017.75 (1.11%)
M.Cap ( in Cr)34181.90

Shareholding Pattern

PROMOTERS 73.66%
NON-INSTITUTION 26.34%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Mercury Laboratories Ltd.

Mercury Laboratories Ltd. was incorporated in the year 1982. Its today's share price is 849. Its current market capitalisation stands at Rs 101.88 Cr. In the latest quarter, company has reported Gross Sales of Rs. 755.59 Cr and Total Income of Rs.766.48 Cr. The company's management includes Jayantilal Raval, Janki R Shah, Paresh Mistry, Bharat Mehta, Dilip R Shah, Rajendra R Shah, Krishna Shah.

It is listed on the BSE with a BSE Code of 538964 , NSE with an NSE Symbol of and ISIN of INE947G01011. It's Registered office is at 18, Shreeji Bhuvan,51, Mangaldas Road,Princess StreetMumbai-400002, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Naresh & Co, RJ Shah & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.